Testing strategies for couple engagement in prevention of mother-to-child transmission of HIV and family health in Kenya: study protocol for a randomized controlled trial.

Antiretroviral therapy (ART) Couple home testing and counseling (CHTC) Couple relationships HIV self-testing kits (HIVST) Intimate partner violence (IPV) Prevention of mother-to-child transmission (PMTCT) Randomized controlled trial (RCT)

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 06 08 2020
accepted: 08 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 22 6 2021
Statut: epublish

Résumé

HIV-related maternal deaths and HIV infection among infants remain unacceptably high across sub-Saharan Africa despite increased antenatal care attendance and provision of antiretroviral therapy to pregnant women. In the Jamii Bora ("Better Family" in Swahili) Study, we seek to test the efficacy of an interdependence theory-based couple intervention. The intervention reaches pregnant women and male partners through home visits by male-female pairs of lay health workers. The aim is to increase access to home-based couples' HIV testing and counseling services to improve family health. This is a three-arm randomized control trial among 1080 pregnant women 15 years of age or older, living with their male partners, and who have not undergone couples' HIV testing and counseling in Kisumu and Migori Counties in Kenya. Couples will be randomized into three groups: home-based couple visits, HIV self-testing kits for couple use, or standard care (male partner clinic invitation letters). Participants will be followed up to 18 months postpartum. The study has three aims: in aim 1, we will determine the effects of the intervention on our primary outcome of couple HIV testing, compared to HIV self-testing kits and standard care; in aim 2, we will examine the intervention impact on HIV prevention behaviors, facility delivery, and postnatal healthcare utilization, as well as secondary health outcomes of maternal viral suppression and HIV-free child survival up to 18 months for couples living with HIV; and in aim 3, we will compare the cost-effectiveness of the home-based couple intervention to the less resource-intensive strategies used in the other two study arms. Assessments with couples are conducted at baseline, late pregnancy, and at months 3, 6, 12, and 18 after birth. The results from this study will inform decision-makers about the cost-effective strategies to engage pregnant couples in the prevention of mother-to-child transmission and family health, with important downstream benefits for maternal, paternal, and infant health. ClinicalTrials.gov NCT03547739 . Registered on May 9, 2018.

Sections du résumé

BACKGROUND BACKGROUND
HIV-related maternal deaths and HIV infection among infants remain unacceptably high across sub-Saharan Africa despite increased antenatal care attendance and provision of antiretroviral therapy to pregnant women. In the Jamii Bora ("Better Family" in Swahili) Study, we seek to test the efficacy of an interdependence theory-based couple intervention. The intervention reaches pregnant women and male partners through home visits by male-female pairs of lay health workers. The aim is to increase access to home-based couples' HIV testing and counseling services to improve family health.
METHODS METHODS
This is a three-arm randomized control trial among 1080 pregnant women 15 years of age or older, living with their male partners, and who have not undergone couples' HIV testing and counseling in Kisumu and Migori Counties in Kenya. Couples will be randomized into three groups: home-based couple visits, HIV self-testing kits for couple use, or standard care (male partner clinic invitation letters). Participants will be followed up to 18 months postpartum. The study has three aims: in aim 1, we will determine the effects of the intervention on our primary outcome of couple HIV testing, compared to HIV self-testing kits and standard care; in aim 2, we will examine the intervention impact on HIV prevention behaviors, facility delivery, and postnatal healthcare utilization, as well as secondary health outcomes of maternal viral suppression and HIV-free child survival up to 18 months for couples living with HIV; and in aim 3, we will compare the cost-effectiveness of the home-based couple intervention to the less resource-intensive strategies used in the other two study arms. Assessments with couples are conducted at baseline, late pregnancy, and at months 3, 6, 12, and 18 after birth.
DISCUSSION CONCLUSIONS
The results from this study will inform decision-makers about the cost-effective strategies to engage pregnant couples in the prevention of mother-to-child transmission and family health, with important downstream benefits for maternal, paternal, and infant health.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03547739 . Registered on May 9, 2018.

Identifiants

pubmed: 33407784
doi: 10.1186/s13063-020-04956-1
pii: 10.1186/s13063-020-04956-1
pmc: PMC7788905
doi:

Banques de données

ClinicalTrials.gov
['NCT03547739']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH116736
Pays : United States
Organisme : NIH/NIMH
ID : R01MH116736

Références

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):427-438
pubmed: 29287029
BMC Pregnancy Childbirth. 2015 Jan 22;15:3
pubmed: 25613487
BMJ Open. 2017 Nov 25;7(11):e018207
pubmed: 29175889
PLoS One. 2019 Mar 13;14(3):e0211921
pubmed: 30865633
Cult Health Sex. 2011 Aug;13(7):829-40
pubmed: 21656411
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):467-473
pubmed: 30148731
BMC Public Health. 2013 Dec 02;13:1115
pubmed: 24294994
PLoS One. 2012;7(7):e40661
pubmed: 22808227
AIDS Care. 2019 Mar;31(3):333-339
pubmed: 30261742
SAHARA J. 2015;12:87-105
pubmed: 26726756
AIDS. 2014 Jan 2;28(1):95-103
pubmed: 23942059
AIDS Behav. 2020 Jul;24(7):2091-2100
pubmed: 31894444
Health Psychol. 1999 Jan;18(1):63-71
pubmed: 9925047
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
PLoS One. 2016 Apr 04;11(4):e0152734
pubmed: 27043707
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
J Int AIDS Soc. 2013 Jul 19;16:18588
pubmed: 23870277
AIDS Care. 2006 Aug;18(6):550-3
pubmed: 16831781
AIDS Behav. 2013 Jun;17(5):1796-808
pubmed: 23479002
Curr HIV/AIDS Rep. 2015 Mar;12(1):1-5
pubmed: 25620530
AIDS Behav. 2013 Jun;17(5):1785-95
pubmed: 23456594
Sex Transm Dis. 2017 Sep;44(9):533-538
pubmed: 28809770
AIDS Behav. 2014 Dec;18(12):2349-58
pubmed: 24077970
Health Psychol. 2005 Nov;24(6):617-622
pubmed: 16287408
Soc Sci Med. 2006 Mar;62(6):1369-80
pubmed: 16146666
Lancet. 2008 Apr 5;371(9619):1165-72
pubmed: 18395577
AIDS Patient Care STDS. 2018 Mar;32(3):92-103
pubmed: 29620927
Glob Health Sci Pract. 2018 Jun 29;6(2):249-256
pubmed: 29959270
AIDS Behav. 2015 Nov;19(11):1949-65
pubmed: 26054390
Lancet. 2006 Oct 7;368(9543):1260-9
pubmed: 17027732
J Epidemiol Community Health. 2015 Jun;69(6):604-12
pubmed: 25700533
Soc Sci Med. 2009 Jun;68(12):2279-87
pubmed: 19427086
AIDS. 2014 Sep 10;28(14):2133-45
pubmed: 25062091
Syst Rev. 2013 Jan 16;2:5
pubmed: 23320454
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):125-6
pubmed: 21799436
Ann Behav Med. 2013 Dec;46(3):285-94
pubmed: 23690283
PLoS Med. 2016 Nov 8;13(11):e1002166
pubmed: 27824882
AIDS Care. 2012;24(9):1173-80
pubmed: 22799618
Sex Transm Infect. 2007 Dec;83(7):547-51
pubmed: 17911136
Pediatr Infect Dis J. 2015 Feb;34(2):168-74
pubmed: 25741969
BMC Health Serv Res. 2020 Feb 5;20(1):92
pubmed: 32024550
AIDS Res Ther. 2011 Feb 28;8:8
pubmed: 21356115
Epidemiol Rev. 2010;32:152-74
pubmed: 20570955
AIDS Care. 2017 Nov;29(11):1417-1425
pubmed: 28355926
Value Health. 2012 Sep-Oct;15(6):812-20
pubmed: 22999130
Lancet HIV. 2016 Jun;3(6):e266-74
pubmed: 27240789
Glob Health Action. 2016 Nov 07;9:33507
pubmed: 27829490
PLoS Med. 2006 Jul;3(7):e261
pubmed: 16834458
J Int AIDS Soc. 2016 Mar 31;19(1):20766
pubmed: 27037140
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8
pubmed: 22267018
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):e172-81
pubmed: 25967269
Trop Med Int Health. 2009 Aug;14(8):849-55
pubmed: 19552646
AIDS Behav. 2013 Feb;17(2):488-97
pubmed: 22130651
BMC Public Health. 2014 Dec 20;14:1309
pubmed: 25526799
AIDS Care. 2002 Dec;14(6):789-800
pubmed: 12511212
AIDS. 2001 May 25;15(8):1045-52
pubmed: 11399987
J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S167-73
pubmed: 27355505
Matern Child Health J. 2016 Mar;20(3):542-9
pubmed: 26525557
AIDS Behav. 2010 Feb;14(1):1-10
pubmed: 18843530
AIDS Care. 2016;28 Suppl 3:59-66
pubmed: 27421052
J Int AIDS Soc. 2012;15(2):17429
pubmed: 22905360
J Sex Res. 2013;50(2):164-77
pubmed: 22206480
AIDS Care. 2015;27(11):1361-6
pubmed: 26608175
Eur J Pain. 2017 Apr;21(4):614-622
pubmed: 27739626
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):404-413
pubmed: 30730356

Auteurs

Zachary Kwena (Z)

Research, Care and Treatment Programme, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya. zkwena@kemri-ucsf.org.

Liza Kimbo (L)

Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Lynae A Darbes (LA)

Center for Sexuality and Health Disparities, Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA.

Abigail M Hatcher (AM)

School of Public Health, University of Witwatersrand, Johannesburg, South Africa.

Anna Helova (A)

Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

George Owino (G)

Research, Care and Treatment Programme, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Harsha Thirumurthy (H)

Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Elizabeth A Bukusi (EA)

Research, Care and Treatment Programme, Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.

Thomas Braun (T)

Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Meredith Kilgore (M)

Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Maria Pisu (M)

Division of Preventive Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Ashutosh Tamhane (A)

Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Van T Nghiem (VT)

Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Kawango Agot (K)

Impact Research and Development Organization, Kisumu, Kenya.

Torsten B Neilands (TB)

Division of Prevention Sciences, Department of Medicine, University of California San Francisco, San Francisco, USA.

Janet M Turan (JM)

Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH